Structures by: Yoon Y. K.
Total: 21
H Cl (H2 O)
ClH3O
Acta Crystallographica (1,1948-23,1967) (1959) 12, 17-20
a=4.05Å b=4.05Å c=4.05Å
α=73.5° β=73.5° γ=73.5°
Ethyl 2-(4-bromophenyl)-1-[3-(1<i>H</i>-imidazol-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate monohydrate
C22H21BrN4O2,H2O
Acta Crystallographica Section E (2011) 67, 11 o3060
a=9.18540(10)Å b=16.7389(2)Å c=13.7379(2)Å
α=90.00° β=98.2830(10)° γ=90.00°
Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>- benzimidazole-5-carboxylate
C23H24F3N3O3
Acta Crystallographica Section E (2011) 67, 5 o1215
a=10.1463(2)Å b=10.5595(2)Å c=11.5775(2)Å
α=96.8680(10)° β=109.6380(10)° γ=110.8330(10)°
Ethyl 2-(4-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1<i>H</i>- benzimidazole-5-carboxylate
C24H27N3O4
Acta Crystallographica Section E (2012) 68, 2 o308-o309
a=10.7455(3)Å b=12.2235(3)Å c=16.1967(4)Å
α=86.1620(10)° β=80.9170(10)° γ=88.2750(10)°
Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(morpholin-4-yl)phenyl]-1<i>H</i>-1,3-benzimidazole-5-carboxylate
C26H32N4O4
Acta Crystallographica Section E (2011) 67, 7 o1772
a=10.3595(3)Å b=20.6870(6)Å c=23.7904(7)Å
α=90.00° β=112.839(2)° γ=90.00°
4'-(4-Chlorophenyl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]- 1,3,1''-trione
C27H20ClNO3
Acta Crystallographica Section E (2011) 67, 9 o2404
a=7.82160(10)Å b=21.2865(3)Å c=14.0641(2)Å
α=90.00° β=116.1560(10)° γ=90.00°
Ethyl 1-[3-(1<i>H</i>-imidazol-1-yl)propyl]-2-(4-chlorophenyl)-1<i>H</i>- benzo[<i>d</i>]imidazole-5-carboxylate dihydrate
C22H21ClN4O2,2(H2O)
Acta Crystallographica Section E (2011) 67, 9 o2405
a=9.06110(10)Å b=13.8393(2)Å c=18.0470(3)Å
α=90.00° β=92.3860(10)° γ=90.00°
Ethyl 4-[3-(1<i>H</i>-imidazol-1-yl)propylamino]-3-nitrobenzoate
C15H18N4O4
Acta Crystallographica Section E (2011) 67, 10 o2606
a=8.4860(4)Å b=8.6175(4)Å c=11.7507(6)Å
α=77.4890(10)° β=81.7320(10)° γ=67.9770(10)°
7'-(4-Bromophenyl)-5',6',7',7a'-tetrahydrodispiro[indan-2,5'- pyrrolo[1,2-<i>c</i>][1,3]thiazole-6',2''-indan]-1,3,1''-trione
C28H20BrNO3S
Acta Crystallographica Section E (2011) 67, 12 o3274
a=10.2871(11)Å b=11.1375(12)Å c=11.5877(13)Å
α=115.511(2)° β=90.075(2)° γ=97.347(2)°
Ethyl 2-(4-nitrophenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C23H24N4O5
Acta Crystallographica Section E (2012) 68, 1 o59
a=9.31250(10)Å b=10.09410(10)Å c=12.9955(2)Å
α=91.9580(10)° β=107.7520(10)° γ=114.4650(10)°
Ethyl 2-(4-hydroxy-3-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate monohydrate
C24H27N3O5,H2O
Acta Crystallographica Section E (2012) 68, 1 o87-o88
a=9.7460(8)Å b=10.0436(8)Å c=12.6072(10)Å
α=85.7370(10)° β=89.684(2)° γ=70.2380(10)°
Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(1<i>H</i>-imidazol-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C23H22N4O4
Acta Crystallographica Section E (2012) 68, 1 o247-o248
a=15.8554(2)Å b=15.3988(2)Å c=16.2292(2)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 2-(1,3-benzodioxol-5-yl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C24H25N3O5
Acta Crystallographica Section E (2012) 68, 2 o471-o472
a=11.1692(2)Å b=11.5498(2)Å c=17.4607(3)Å
α=90.00° β=109.2100(10)° γ=90.00°
Ethyl 1-[3-(2-oxopyrrolidin-1-yl)propyl]-2-phenyl-1<i>H</i>- benzimidazole-5-carboxylate
C23H25N3O3
Acta Crystallographica Section E (2012) 68, 2 o251-o252
a=9.9469(3)Å b=10.5845(3)Å c=11.3184(3)Å
α=69.6790(10)° β=67.3740(10)° γ=70.1350(10)°
Ethyl 1-phenyl-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>-benzimidazole-5-carboxylate
C23H17F3N2O2
Acta Crystallographica Section E (2012) 68, 6 o1864-o1865
a=9.8548(2)Å b=25.0714(6)Å c=16.0566(4)Å
α=90.00° β=107.0230(10)° γ=90.00°
Ethyl 4-anilino-3-nitrobenzoate
C15H14N2O4
Acta Crystallographica Section E (2012) 68, 6 o1684
a=10.6464(2)Å b=9.9178(2)Å c=14.7885(2)Å
α=90.00° β=120.2440(10)° γ=90.00°
Ethyl 2-(4-chlorophenyl)-1-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C22H17ClN2O2
Acta Crystallographica Section E (2012) 68, 6 o1863
a=9.3357(2)Å b=9.7982(2)Å c=11.7718(4)Å
α=107.502(2)° β=102.106(2)° γ=109.5390(10)°
Ethyl 2-(4-bromophenyl)-1-phenyl-1<i>H</i>-benzimidazole-5-carboxylate
C22H17BrN2O2
Acta Crystallographica Section E (2012) 68, 6 o1683
a=9.3121(2)Å b=9.8136(2)Å c=11.8458(2)Å
α=108.2170(10)° β=101.1350(10)° γ=109.3610(10)°
Ethyl 1-phenyl-2-[4-(trifluoromethoxy)phenyl]-1<i>H</i>-benzimidazole-5-carboxylate
C23H17F3N2O3
Acta Crystallographica Section E (2012) 68, 9 o2715-o2716
a=8.0204(4)Å b=10.8943(6)Å c=11.4329(7)Å
α=76.706(4)° β=83.269(4)° γ=81.227(4)°
Ethyl 2-[4-(morpholin-4-yl)phenyl]-1-[3-(2-oxopyrrolidin-1-yl)propyl]- 1<i>H</i>-1,3-benzimidazole-5-carboxylate monohydrate
C27H32N4O4,H2O
Acta Crystallographica Section E (2012) 68, 10 o2967-o2968
a=12.2602(3)Å b=13.7267(4)Å c=15.3163(4)Å
α=99.3570(10)° β=93.7000(10)° γ=94.0030(10)°
3-{5-Ethoxycarbonyl-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1<i>H</i>- benzimidazol-2-yl}benzoic acid
C24H25N3O5
Acta Crystallographica Section E (2013) 69, 2 o304
a=9.3097(3)Å b=24.8252(7)Å c=9.6761(3)Å
α=90.00° β=112.3220(10)° γ=90.00°